Taipei, Taiwan

Han Chun Ou


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Han Chun Ou: Innovator in Controlled Drug Release Technology

Introduction

Han Chun Ou is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug delivery systems. His innovative work focuses on enhancing the efficacy of therapeutic agents through advanced liposome compositions.

Latest Patents

Han Chun Ou holds a patent for a "Controlled drug release liposome composition." This invention relates to a pharmaceutical composition that includes at least one liposome, a polyvalent counterion donor or a pharmaceutically acceptable salt thereof, a monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The patent also outlines methods for inhibiting cancer cell growth by administering the described pharmaceutical composition.

Career Highlights

Throughout his career, Han Chun Ou has worked with prominent companies in the biopharmaceutical sector. He has been associated with Tlc Biopharmaceuticals, Inc. and Taiwan Liposome Company, Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Han Chun Ou has collaborated with esteemed colleagues, including Pei Kan and Yun-Long Tseng. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Han Chun Ou's work in controlled drug release technology exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for more effective cancer treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…